Prof. Werner Hohenberger – Erlangen, Germany



Long-term President of the German Association of Coloproctology, President of the German Cancer Society, President of the European Association of Coloproctology, President of the Bavarian Society of Surgery; Member of the German Academy of Sciences Leopoldina, Visiting Professor at the Department of Colorectal Surgery,Cleveland Clinics, Ohio (USA) and the Peking University People’s Hospital (China), Honorary Member of German Cancer Aid and about a dozen international surgical oncology, general and coloproctology associations; honoured with some of the highest scientific distinctions including the Gold Zenker Medal of the German Society of Surgery or the German Cancer Award; founder of Europe's leading Colorectal Cancer Centre; initiator and pioneer of CME (Complete Mesocolic Excision).

Prof. Paolo Delrio – Naples, Italy



President of the Italian Society of Surgical Oncology; Head of Colorectal Surgical Oncology-Abdominal Oncology Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione Giovanni Pascale IRCCS, Naples, Italy; author of over 200 papers on advanced techniques in colorectal surgery; research on the applications of techniques including TAMIS, taTME, TME and HIPEC; promoter and initiator of research projects into applications of minimally invasive techniques in surgical oncology and modern pre- and postoperative diagnostics.

Prof. Olivier Glehen – Lyon, France



Head of the Department of Surgical Oncology, CHU Lyon Sud, Hospices Civils de Lyon, University of Lyon, Pierre Bénite, Lyon, France; Prof. Glehen's Department is one of the world's leading medical centres performing cytoreductive surgery in combination with HIPEC, with a track record of approximately 150 procedures annually in recent years; in 2002–2003 immediate assistant to Prof. Paul Sugarbaker – originator of the technique; author of ca. 120 papers on CRS + HIPEC with an h-index of over 27; expert in the treatment of peritoneal carcinomatosis, therapy of liver metastases and stomach cancer surgery; initiator of the Big Renape research group – a project for comprehensive multi-centre assessment of the treatment of patients with peritoneal carcinomatosis and the HIPEC technique.

Prof. Marc Reymond – Tübingen, Germany



Professor at the Department of Surgery, University of Tübingen; originator of an innovative minimally invasive drug delivery technique in intraperitoneal chemotherapy; specialist in gastrointestinal surgical oncology and peritoneal carcinomatosis; chief editor of the journal “Pleura and Peritoneum”; author of over 200 publications; currently one of the most frequently cited authors in the field of innovative surgical oncology techniques; founder of a leading research group studying a new methodology of surgical treatment of gastrointestinal cancers and peritoneal carcinomatosis including modern drug delivery systems.

Prof. Hyung-Ho Kim – Seoul, Korea



One of the most recognized experts worldwide in the application of laparoscopic techniques in gastric cancer treatment; together with his team performed 5,000 laparoscopic gastric surgical procedures, achieving in 2006 the top result worldwide in terms of implementation of laparoscopic techniques; a foundation member of the KLASS study group; in 2012–2015 principal investigator of the KLASS01 trial comparing laparoscopic gastrectomy with open gastrectomy; editor of scientific journals and reviewer in about a dozen periodicals in the field of surgery, surgical oncology and gastroenterology; founder of Asia's largest centre for laparoscopy and gastric cancer treatment; President of the Korean Cancer Association; president and supervisor of the KLASS project; one of the most frequently cited authors in the field of minimally invasive surgical techniques in gastric cancer; expert lecturer of a number of Asian and American medical associations.

Prof. Jan Dumanski – Uppsala, Sweden



Professor at the Department of Immunology, Genetics and Pathology and SciLifeLab, Uppsala University; eminent scientist and specialist in experimental pathomorphology, genetics and immunology; in 2006–2008 involved in research at the University of Alabama; author of multiple publications on topics related to the role and theories of genetic mechanisms underlying the process of metastasizing and predisposition for carcinogenesis; Prof. Dumanski has been actively engaged in research aimed at the characterization of the human chromosome 22; frequently cited in the most up-to-date publications in the field of surgical oncology, oncology and experimental oncology.

Prof. Samy Lewiz Habib – San Antonio, USA



Representative of University of Texas Health Science Centre at San Antonio, USA, and South Texas Veterans Health Care System, San Antonio, USA. Internationally recognized expert in research on the molecular basis of carcinogenesis and advanced techniques of targeted cancer treatment. Specialist in studies using in vivo and in vitro models. Author of about 100 publications with a high citation index on topics listed above. A number of Prof. Habib's research assumptions and conclusions are currently adopted as recommendations in international preclinical studies in experimental oncology and surgery. For his research, Prof. Habib has been awarded a remarkable number of grants including some provided by such prestigious organizations as the National Institutes of Health (NIH) or the United States Department of Defense.

Dr. Martin Hübner – Lausanne, Switzerland



Employed at the Department of Visceral Surgery, University Hospital of Lausanne (CHUV); expert in colorectal and peritoneal surface surgery; head of the clinical team specializing in the treatment of carcinomatosis; editor of specialist journals in the fields of surgical oncology and colorectal surgery; member of the French Academy of Sciences; examiner of Swiss medical organizations; examiner and expert of the European Association of Coloproctology; specialist in ERAS (enhanced recovery after surgery); member of the ESPEN group, co-author of the majority of recommendations and guidelines concerning ERAS.

Dr. Andrea Muratore – Turin, Italy



Employed at the Oncological Surgical Department of Candiolo Cancer Institute – FPO-IRCC; expert in laparoscopic and minimally invasive procedures in colorectal and hepatobiliary surgery; conducts advanced courses in laparoscopic surgery; author of 76 research papers with a high citation index; expert for multiple scientific journals on laparoscopy in surgical oncology; pioneer in the introduction of innovative methods for the treatment of colorectal cancer with a special focus on the taTME technique and single-port procedures.


And many more.